NCT01186757View on ClinicalTrials.gov

Multiple Dose Healthy Volunteer Study of PF-03715455.

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Healthy Volunteers

Interventions

DRUG

PF-03715455

PF-03715455 1.6 mg BID

DRUG

PF-03715455

PF-03715455 4mg BID

DRUG

PF-03715455

PF-03715455 10 mg BID

DRUG

Placebo

Placebo

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY